U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. Information by Drug Class
  5. Phase-Out of CFC Metered-Dose Inhalers Containing flunisolide, triamcinolone, metaproterenol, pirbuterol, albuterol and ipratropium in combination, cromolyn, and nedocromil
  1. Information by Drug Class

Phase-Out of CFC Metered-Dose Inhalers Containing flunisolide, triamcinolone, metaproterenol, pirbuterol, albuterol and ipratropium in combination, cromolyn, and nedocromil

Metered dose inhalers (MDIs) that contain chlorofluorocarbons (CFC) to deliver these medicines are being phased out over the coming years. Patients who use these medicines will need to talk to a doctor and switch to another medicine before the phase out of their medicine is completed. 

Phase-Out

General Information

Regulatory Documents

ResourcesForYou

Back to Top